(Q48908172)

16 February 2018

reason for preferred rank

title

Presynaptic alpha2-adrenoceptor function and sleep in man: Studies with clonidine and idazoxan (English)

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

26 October 2022

Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677168

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

26 October 2022

author name string

A. N. Nicholson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677168

26 October 2022

P. A. Pascoe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677168

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1677168

26 October 2022

publication date

1 April 1991

1 reference

16 February 2018

full work available at URL

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:002839089190062G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

https://api.elsevier.com/content/article/PII:002839089190062G?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

26 October 2022

1 reference

16 February 2018

volume

30

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

367-372

1 reference

16 February 2018

Effect of clonidine on sleep patterns in man

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

An Analysis of Transformations

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Rilmenidine selectivity for imidazoline receptors in human brain

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Sleepiness and nap sleep following a morning dose of clonidine.

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Effects of the alpha 2-antagonist idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Comparison of the ?-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Studies on RX 781094: a selective, potent and specific antagonist of α2-adrenoceptors

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

New Tables for Multiple Comparisons with a Control

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Idazoxan (RX 781094) selectively antagonizes α2-adrenoceptors on rat central neurons

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Involvement of pre- and postsynaptic receptors in catecholaminergic control of paradoxical sleep in man

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Effect of clonidine and yohimbine on sleep in man: polygraphic study and EEG analysis by normalized slope descriptors

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Clonidine and Sympathetic Activity during Sleep

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

REM sleep and depression: common neurobiological control mechanisms

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor.

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Rapid eye movement sleep and sleep continuity. Depression and antidepressants

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Dopaminergic transmission and the sleep-wakefulness continuum in man.

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Histaminergic systems and sleep. Studies in man with H1 and H2 antagonists.

26 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Modulation of catecholamine transmission and sleep in man.

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Modulation of sleep by trimipramine in man.

26 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Comparison of the effects of recently developed alpha 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain.

26 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

3HRX 781094: A new antagonist ligand labels α2-adrenoceptors in the rat brain cortex

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: competition studies with [3H]prazosin and [3H]idazoxan

26 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Effects of central dopaminergic blockade with pimozide upon the EEG stages of sleep in man

26 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Lack of involvement of α2-adrenoceptors in the regulation of striatal dopaminergic transmission

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Enhanced noradrenergic neuronal activity increases homovanillic acid levels in cerebrospinal fluid

26 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluid

26 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects

26 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

26 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

Effects of idazoxan on catecholamine systems in rat brain.

26 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0028-3908(91)90062-G

26 October 2022

Identifiers

1 reference

16 February 2018

1 reference

16 February 2018